Tuesday, 02 January 2024 12:17 GMT

Smiths Medical Issues Urgent Medical Device Correction Informing Customers Of A Potential Issue With Certain Sizes Of Intubation ORAL/NASAL Endotracheal Tubes Being Smaller Than Expected


(MENAFN- PR Newswire)

MINNEAPOLIS, March 7, 2025 /PRNewswire/ -- Smiths Medical has issued an Urgent Medical Device Correction to notify affected global customers of a potential issue with the 2.0, 2.5, 3.0 and 3.5 mm sizes of Intubation ORAL/NASAL Endotracheal Tube products being smaller than expected.

If the diameter of the device is smaller than expected, it may potentially result in inadequate ventilation to the patient, post-insertion of the endotracheal tube. In such situations, the patient may experience hypoxia, underdose, and/or cardiopulmonary collapse which may lead to death. To date, Smiths Medical has received eight (8) reports of serious injury that are potentially related to this issue.

All impacted customers and distributors were sent a letter outlining the risk and providing specific steps to determine whether their devices are affected or not and what steps to follow if they have affected product in service. A copy of that letter as well as a list of affected products can be accessed on ICU Medical's website here . Products were manufactured from 01 October 2019 to 03 October 2024 and distributed from 30 October 2019 to 16 December 2024.

For further inquiries, please contact Smiths Medical using the information provided below.

Smiths Medical Contact

Contact Information

Areas of Support

Global Complaint Management

[email protected]

1-(866)-216-8806

To report adverse events or product complaints

Customer Service

[email protected]

1-(800)-259-5361

Questions about your product and/or replacement

Field Action Processing

[email protected]

1-(877)-877-0317

Questions about this

communication

The U.S. Food and Drug Administration (FDA) has been notified of this action.

Adverse reactions or quality problems experienced with this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail, or by fax.

  • Complete and submit the report Online:
  • Regular Mail or Fax: Download form or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178

Media Contact:
Harrison Richards
949-366-4261
[email protected]

SOURCE Smiths Medical

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE? 440k+
Newsrooms &
Influencers 9k+
Digital Media
Outlets 270k+
Journalists
Opted In GET STARTED

MENAFN07032025003732001241ID1109290113



PR Newswire

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Search